Series A - MycoMedica Life Sciences, PBC

Series A - MycoMedica Life Sciences, PBC

Investment Firm

Overview

Psychedelic Medicines

Announced Date

Jun 01, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

KittyHawk

KittyHawk

KittyHawk is a early_stage_venture and secondary_market and seed firm.

Participant Investors

4

Investor Name
Participant InvestorZen Chu
Participant InvestorKittyHawk
Participant InvestorObvious Ventures
Participant InvestorTrue Ventures

Round Details and Background

MycoMedica Life Sciences, PBC raised $60000000 on 2022-06-01 in Series A

Psychedelic Medicines

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 25, 2021
Seed Round - MycoMedica Life Sciences, PBC
2-8.0M
Jun 01, 2022
Series A - MycoMedica Life Sciences, PBC
4-60.0M
Jul 12, 2021
Series A - MycoMedica Life Sciences, PBC
1-undefined

Recent Activity

There is no recent news or activity for this profile.